Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$24.46 USD
+2.19 (9.83%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $24.43 -0.03 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ASMB 24.46 +2.19(9.83%)
Will ASMB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ASMB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASMB
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates
ASMB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock?
BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround
Other News for ASMB
ASMB Crossed Above 20 Day Moving Average on September 20
Is ASMB ready to move higher? Crossed Above 50 Day Moving Average shows up after rallying 8.0%
NR7 appears for ASMB after 0.34% move
Is ASMB consolidating before a move? Calm After Storm shows up after sinking 3.02%
Is ASMB positioned for a breakdown? Fell Below 50 Day Moving Average shows up after slipping 3.02%